Featured

[Special Report] Trademark filing and litigation trends 2024: Insights and opportunities

Robert Reading

Director, Corporate Strategy, Content at Clarivate

Biopharma
What a string of semaglutide biosimilars could mean for Mainland China
Academia and Government
Introducing the Clarivate Academic AI Platform
Life Sciences and Healthcare
May 28, 2015
Life Sciences and Healthcare
February 19, 2015
Intellectual Property
January 2, 2015
Life Sciences and Healthcare
February 3, 2014